Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension

Hypertension

Volumn 32, Issue 4, 1998, Pages 676-682

  Sharma, Pankaj ^a,c   Hingorani, Aroon ^a   Jia, Haiyan ^a   Ashby, Mike ^a   Hopper, Ruth ^a   Clayton, David ^b   Brown, Morris J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Catecholamines; Genetics; Hypertension, essential; Microsatellite marker; Molecular biology; Tyrosine hydroxylase

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031723753     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.4.676     Document Type: Article

References (26)

1. Goldstein DSK. Plasma catecholamines and essential hypertension: an analytical review. Hypertension. 1983;5:86-99.
2. Brown MJ, Causon RC, Barnes VF, Brennan P, Barnes G, Greenberg G. Urinary calecholamines in essential hypertension: results of 24-hour urine catecholamine analyses from patients in the Medical Research Council Trial for mild hypertension and from matched controls. Q J Med. 1985; 57:637-651.
3. O'Malley KL, Anhalt MJ, Martin BM, Kelsoe JR, Winfield SL, Ginns EI. Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry. 1987;26:6910-6914.
4. Grima B, Lamouroux A, Boni C, Julien J, Javoy AF, Mallet J. A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature. 1987;326:707-711.
5. Zhou Q, Qualfe CJ, Palmiter RD. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature. 1995;374:640-643.
6. Kaneda N, Sasaoka T, Kobayashi K, Kiuchi K, Nagatsu I, Kurosawa Y, Fujita K, Yokoyama M, Nomura T, Katsuki M, Nagatsu T. Tissue-specific and high-level expression of the human tyrosine hydroxylase gene in transgenic mice. Neuron. 1991;6:583-594.
7. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene. Nucleic Acids Res. 1991;19:3753. Abstract.
8. Meloni R, Leboyer M, Bellivier F, Barbe B, Samolyk D, Allilaire JF, Mallet J. Association of manic-depressive illness with tyrosine hydroxylase microsatellite marker. Lancet. 1995;345:932. Letter.
9. Ludecke B, Bartholome K. Frequent sequence variant in the human tyrosine hydroxylase gene. Hum Genet. 1995;95:716.
10. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19:5444.
11. Jenner DA, Brown MJ, Lhoute FJM. Determination of a-methyldopa, a-methylnoradrenaline, noradrenaline and adrenaline in plasma high performance liquid chromatography with electrochemical detection. J Chromatogr. 1981;224:507-512.
12. Lathrop GM. Estimating genotype relative risk. Tissue Antigens. 1983; 22:160-166.
13. Holmans P, Clayton D. Efficiency of typing unaffected relatives in an affected-sib-pair linkage study with single-locus and multiple tightly linked markers. Am J Hum Genet. 1995;57:1221-1232.
14. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994;79:407-414.
15. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet. 1995;11:76-82.
16. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S. Lalouel J. A chimaeric 11b-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
17. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11b-hydroxysteroid dehydrogenase. Nat Genet. 1995;10:394-399.
18. Undlien DE, Bennett ST, Todd JA, Akselsen HE, Ikaheimo I, Reijonen H, Knip M, Thorsby E, Ronningen KS. Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes. 1995;44: 620-625.
19. Caulfield M, Newell-Price J. The angiotensin converting enzyme gene in cardiovascular disease. Br Heart J. 1995;74:207-208.
20. Sharma P. Genes for ischaemic stroke: strategies for their detection. J Hypertens. 1996;14:277-285.
21. Williams PD, Puddey IB, Beilin LJ, Vandongen R. Genetic influences on plasma catecholamines in human twins. J Clin Endocrinol Metab. 1993; 77:794-799.
22. Miller JZ, Luft FC, Grim CE. Genetic influences on plasma and urinary norepinephrine after volume expansion and contraction in normal men. J Clin Endocrinol Metab. 1980;50:219-222.
23. Bennett ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Ronningen KS, Barnett AH, Bain SC, Todd JA. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisalellite locus. Nat Genet. 1995;9:284-292.
24. Brown MJ. The causes of essential hypertension. Br J Clin Pharmacol. 1996;42:21-27.
25. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-1517.
26. Risch N, Merikangas K. Genetic analysis of complex diseases. Science. 1997;275:1329-1330.